White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 2: Detailing to HCPs
Each Pfizer product has an Asset Team which creates promotional materials and messaging for that
product. These materials and messaging are reviewed and approved by a Review Committee (RC)
that includes a cross-disciplinary group of colleagues from Marketing, Medical, Regulatory Affairs
and Legal.
Key Points: Permitted vs. Prohibited Activities
Permitted Prohibited
Using promotional materials that have been
approved by the relevant RC
Marking a training copy of your clinical reprint
(that you don't show to HCPs) to help you learn
key points
Using the highlighting function in iCUE as
appropriate
Leaving a handwritten thank you note that
includes the name of the product but does not
make any direct or indirect product claim
Using Pfizer training materials and other
“Do Not Detail” pieces for your education only
21
Showing a chart that you put together based on
two RC-approved pieces
Using any unapproved item as a visual aid to
illustrate a point or concept (e.g., pill bottles,
money, food, candy, water bottles)
Showing an HCP any promotional material that
has been marked or altered in any way (e.g., no
highlighting outside of the iCUE functionality,
and no sticky notes, handwritten notes, check
marks, arrows, etc.)
Leaving a thank you note that contains more
than the name of a product, including any direct
or indirect product claim (e.g., mentioning
indications or disease state information)
Showing Pfizer training materials or other
“Do Not Detail” pieces to customers
Rev. 09/12
Page 6 of 29